Tumor-derived IL-6 may contribute to the immunological defect in CLL

Leukemia. 2008 May;22(5):1084-7. doi: 10.1038/sj.leu.2405015. Epub 2007 Nov 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interleukin-6 / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Neoplasm Proteins / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology

Substances

  • Interleukin-6
  • Neoplasm Proteins